Tejara Capital LTD Karyopharm Therapeutics Inc. Transaction History

Tejara Capital LTD

  • $210 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
$0.68 - $1.31 $31,307 - $60,312
-46,040 Reduced 4.27%
1,031,348 $892 Million
Q3 2023

Nov 13, 2023
SELL
$1.14 - $1.81 $75,927 - $120,551
-66,603 Reduced 5.82%
1,077,388 $1.44 Billion
Q2 2023

Aug 11, 2023
BUY
$1.79 - $4.59 $1.15 Million - $2.95 Million
642,429 Added 128.09%
1,143,991 $2.05 Billion
Q4 2022

Feb 13, 2023
BUY
$2.48 - $5.93 $1.24 Million - $2.97 Million
501,562 New
501,562 $1.71 Billion

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $64.6M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Tejara Capital LTD Portfolio

Follow Tejara Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tejara Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email